Baseline ctDNA analyses and associations with outcomes in taxane-naive patients with mCRPC treated with (177)Lu-PSMA-617 versus change of ARPI in PSMAfore Meeting Abstract


Authors: De Bono, J. S.; Morris, M. J.; Sartor, O.; Wei, X. X.; Fizazi, K.; Herrmann, K.; Piulats, J. M.; Mahammedi, H.; Logothetis, C.; George, D. J.; Eldjerou, L. K.; Wong, C.; Barys, L.; Rajagopal, N.; Rodosthenous, T.; Chi, K. N.
Abstract Title: Baseline ctDNA analyses and associations with outcomes in taxane-naive patients with mCRPC treated with (177)Lu-PSMA-617 versus change of ARPI in PSMAfore
Meeting Title: 2024 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 16 Suppl.
Meeting Dates: 2024 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001275557401255
PROVIDER: wos
DOI: 10.1200/JCO.2024.42.16_suppl.5008
Notes: Meeting Abstract: 5008 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    577 Morris